Status:

COMPLETED

Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis

Lead Sponsor:

University of South Florida

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Precancerous Condition

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis. PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it works in tre...

Detailed Description

OBJECTIVES: * Evaluate the effects of losartan potassium on disease progression in patients with idiopathic pulmonary fibrosis. * Determine the safety of this drug in these patients. OUTLINE: This i...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Age \> 21 years
  • Diagnosis of idiopathic pulmonary fibrosis
  • Patients taking Coumadin and/or N-acetylcysteine may participate in the study
  • Baseline forced vital capacity (FVC) must be greater than or equal to 50%
  • Baseline 6 minute walk test distance walked must be greater than or equal to 200 meters not requiring greater than 6 lpm of oxygen
  • EXCLUSION CRITERIA:
  • Pregnant, intending to become pregnant or breastfeeding
  • Current or previous smoker of cigarettes or marijuana that recently quit within the last 6 months prior to enrollment
  • Allergy or allergic reaction to Losartan or any other angiotensin II receptor blocker
  • Taking losartan or any other angiotensin II receptor blocker
  • Baseline systolic blood pressure \< 100 mmHg
  • Currently taking or has taken immunosuppressant agents within the last month such as azathioprine, cyclophosphamide, colchicine and/or prednisone
  • History of lung transplant
  • History of kidney failure or liver disease
  • Inability to attend clinic visits

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2012

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT00879879

    Start Date

    March 1 2009

    End Date

    March 1 2012

    Last Update

    February 21 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Cincinnati

    Cincinnati, Ohio, United States, 45267